The Procter & Gamble Company
PG
$150.65
$0.180.12%
NYSE
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Revenue | 20.89B | 19.78B | 21.88B | 21.74B | 20.53B |
Total Other Revenue | -- | -- | -- | -- | -- |
Total Revenue | 20.89B | 19.78B | 21.88B | 21.74B | 20.53B |
Cost of Revenue | 10.63B | 9.67B | 10.39B | 10.38B | 10.30B |
Gross Profit | 10.26B | 10.11B | 11.49B | 11.36B | 10.23B |
SG&A Expenses | 5.90B | 5.50B | 5.54B | 5.32B | 6.27B |
Depreciation & Amortization | -- | -- | -- | -- | -- |
Other Operating Expenses | -- | -- | -- | -- | -- |
Total Operating Expenses | 16.53B | 15.17B | 15.93B | 15.70B | 16.57B |
Operating Income | 4.36B | 4.61B | 5.95B | 6.04B | 3.96B |
Income Before Tax | 4.52B | 4.66B | 5.85B | 5.14B | 3.87B |
Income Tax Expenses | 895.00M | 868.00M | 1.19B | 1.15B | 726.00M |
Earnings from Continuing Operations | 3.63B | 3.79B | 4.66B | 3.99B | 3.14B |
Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
Minority Interest in Earnings | -11.00M | -23.00M | -29.00M | -28.00M | -7.00M |
Net Income | 3.62B | 3.77B | 4.63B | 3.96B | 3.14B |
EBIT | 4.36B | 4.61B | 5.95B | 6.04B | 3.96B |
EBITDA | 5.08B | 5.30B | 6.65B | 6.76B | 4.72B |
EPS Basic | 1.51 | 1.58 | 1.94 | 1.65 | 1.30 |
Normalized Basic EPS | 1.18 | 1.25 | 1.55 | 1.59 | 1.08 |
EPS Diluted | 1.48 | 1.54 | 1.88 | 1.61 | 1.27 |
Normalized Diluted EPS | 1.15 | 1.19 | 1.49 | 1.52 | 1.06 |
Average Basic Shares Outstanding | 2.39B | 2.35B | 2.35B | 2.36B | 2.41B |
Average Diluted Shares Outstanding | 2.44B | 2.45B | 2.46B | 2.47B | 2.47B |
Dividend Per Share | 1.06 | 1.01 | 1.01 | 1.01 | 1.01 |
Payout Ratio | 70.62% | 64.55% | 52.72% | 61.76% | 78.07% |